Skip to main content

Table 3 Geriatric subgroups

From: Clinical outcomes in patients receiving edoxaban or phenprocoumon for prevention of stroke in atrial fibrillation: a German real-world cohort study

Geriatric Subgroups

Edoxaban

Phenprocoumon

n

%

n

%

Age

 < 65 years

1,454

18.2%

1,306

9.8%

65–74 years

2,238

28.1%

3,295

24.7%

 ≥ 75 years

4,283

53.7%

8,718

65.5%

Comorbidity

High CCI score

2,698

33.8%

6,156

46.2%

Low CCI score

5,277

66.2%

7,163

53.8%

Frailty

Frail

3,513

44.1%

7,131

53.5%

Not frail

4,462

55.9%

6,188

46.5%

Polypharmacy

Polypharmacy

2,912

36.5%

6,231

46.8%

No polypharmacy

5,063

63.5%

7,088

53.2%

  1. Abbreviation: CCI Charlson Comorbidity Index